The dipeptidyl peptidase-1 (DPP1) inhibitor brensocatib became the first licensed therapy for bronchiectasis in the USA and Europe in 2025,1 based on the phase 3 ASPEN trial showing an approximate 20% ...
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...
A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
UK charity warns against excessive academic pressure and suggests reducing the number of high-stakes tests Exam stress at age 15 can increase the risk of depression and self-harm into early adulthood, ...
Teams have gathered in Bahrain for two weeks of pre-season testing ahead of the highly-anticipated 2026 F1 season. Preparations are ramping up for F1’s brave new era of regulations, with all 11 teams ...
-- Company to host a live webcast event with an expert panel of clinicians during ASH -- REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell ...
A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...
A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...
A simple, though not necessarily easy, test may help predict how many years a person has left, according to exercise researchers who have been tracking thousands of middle-aged and older people for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results